A CASE SERIES ON BLADDER PAIN SYNDROME (BPS) ADDRESSED BY MODIFIED DRUG COMBINATION DURING COVID 19 PANDEMIC.-Reference-Cited by-同舟云学术

A CASE SERIES ON BLADDER PAIN SYNDROME (BPS) ADDRESSED BY MODIFIED DRUG COMBINATION DURING COVID 19 PANDEMIC.

Published:2022-02-01 Issue: Volume: Page:67-68
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Mohan Midhun,Alexander Roshni,R Nair Kannan

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a symptom complex characterized by persistent and frequent pain in the suprapubic area along with urgency, frequency, discomfort, or pressure, this is a case series of three patients with presentation of symptoms peculiar to BPS with its identication and management. The intent is to highlight the effectiveness of a modied combination of already existing approved cocktails to treat BPS / IC. The drug combination was administered intravesicaly as 6 cycles with one week gap in between. The improvements were later assessed using ICIQ-OAB and WHOQOL-BREF questionnaire.

Publisher

World Wide Journals

Reference5 articles.

1. Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D et al. Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol. 2020;27:578-589.

2. Bitcon C , Anderson K , Cox A. Treatment of interstitial cystitis/bladder pain syndrome: a contemporary review.EMJ. 2020;5:91-100.

3. Cox A, Golda N, Nadeau G, Curtis Nickel J, Carr L, Corcos J et al. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10:E136-E155.

4. Meng E, Hsu YC, Chuang YC. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). Low Urin Tract Symptoms. 2018;10:3-11.

5. Digesu GA, Tailor V, Bhide AA, Khullar V. The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS? Int Urogynecol J. 2020;31:1387-1392.